Evidence map›Paper›PMID 40427146›Full record

ArticleCancers2025

Exosome Enveloped by Nano Lipid Particle a New Model for Signal Transducer and Activator of Transcription 3 Silencer Ribonucleic Acid Delivery System to a Glioblastoma Mice Model.

Amir Monfaredan, Sena Şen, Alaviyehsadat Hosseininasab, Didem Taştekin, Ghazaleh Fazli, Hamza Uğur Bozbey, Nasrin Yousefi, Merve Hocaoğlu, Mustafa Oral Öncül, Rıdvan Seçkin Özen

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amir MonfaredanDepartment of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran 1416753955, Iran.
Sena ŞenDepartment of Basic Oncology, Oncology Institute, Istanbul University, 34093 Istanbul, Türkiye.ORCID 0000-0003-3967-8903
Alaviyehsadat HosseininasabGeneDia Life Science Company, Tehran 1416753955, Iran.ORCID 0000-0003-2290-1005
Didem TaştekinDepartment of Clinic Oncology, Oncology Institute, Istanbul University, 34093 Istanbul, Türkiye.
Ghazaleh FazliDepartment of Developmental Biology, Science and Research Branch, Islamic Azad University, Tehran 1477893780, Iran.
Hamza Uğur BozbeyDepartment of Clinic Oncology, Oncology Institute, Istanbul University, 34093 Istanbul, Türkiye.
Nasrin YousefiDepartment of Developmental Biology, Science and Research Branch, Islamic Azad University, Tehran 1477893780, Iran.
Merve HocaoğluIstanbul Genetics Group, Genetic Disorders Evaluation Center, 34365 Istanbul, Türkiye.ORCID 0009-0009-9094-8957
Mustafa Oral ÖncülDepartment of Infectious Diseases and Clinical Microbiology, Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, Türkiye.
Rıdvan Seçkin ÖzenIstanbul Genetics Group, Genetic Disorders Evaluation Center, 34365 Istanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

blood–brain barrierexosome-based therapyglioblastomasiRNA deliverySTAT3 inhibition

Identifiers

PMID40427146
PMCPMC12109797

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.